ACAD review from Biopharma | ACAD Message Board Posts


ACADIA Pharmaceuticals Inc.

  ACAD website

ACAD   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  19639 of 19664  at  1/13/2023 10:47:01 AM  by

Paul777333


 In response to msg 19637 by  BelieverTim
view thread

Re: ACAD review from Biopharma

 Acadia is now only 9.5% of my portfolio now.  I keep a spreadsheet with a column that shows the percent of holdings for each stock.  This gets updated automatically based on the stock prices.  Lucky for me I stuck with keeping my Acadia investment to no more than 20% of my portfolio at the time of purchase.  Of course, that number changes as my stocks go up and down.  This is what saved me on Acadia.
 
I also lucked out on ITCI.  My average buy-in on that is $15.51.  Even if you average in my ITCI gains, my total returns for Biotech over the years were below-par considering the risk.   Here are my returns for me biotechs:
NERV - 0% - I sold out at break-even after being up significantly.
ITCI  193% (gain)
ACAD  -36% (loss)
NERV - Breakeven
 
My total gain from all three is only 29%.  When considering the length of time I have held these investments it has been a return well below what the S&P has done over the same period of time.
 
My only gain with ITCI was almost pure luck as they were not expected to get approval.  Once I dump ITCI and ACAD I will likely keep my biotech stocks to a minimum in my portfolio.  I am looking for an exit for both.
 
 
 
 
 
 
 


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 4  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board




Financial Market Data provided by
.
Loading...